Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr: A Phase III, Randomized Controlled Clinical Trial

NCT05421650 is registered in ClinicalTrials.gov with CHA University as lead sponsor.

NCT NCT05421650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05421650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr: A Phase III, Randomized Controlled Clinical Trial
Lead sponsor
CHA University
Phase
Not applicable
Overall status
Recruiting
Start date
August 1, 2022
Completion date
December 31, 2030
Enrollment
240 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer